ID

24291

Descrizione

Study ID: 100468 Clinical Study ID: AVA100468 Study Title: An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Avandia XR,Rosiglitazone XR,Avandia Study Indication: Alzheimer's Disease Study Conclusion

Keywords

versioni (1)
  1. 28/07/17 28/07/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

28 luglio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC-ND 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

Inglese

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

1 moduli  
Patient Information
Descrizione

Patient Information

Alias
UMLS CUI-1
C1955348
Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Pregnancy Information
Descrizione

Pregnancy Information

Alias
UMLS CUI-1
C0032961
Did the subject become pregnant during the study?
Descrizione

If Yes, complete Pregnancy Notification form.

Tipo di dati

text

Alias
UMLS CUI [1]
C0032961
Study Conclusion
Descrizione

Study Conclusion

Alias
UMLS CUI-1
C1707478
Date of subject completion or withdrawal
Descrizione

Completion, Withdrawal

Tipo di dati

date

Unità di misura
  • dd-mmm-yy
Alias
UMLS CUI [1]
C0805732
UMLS CUI [2]
C2349954
dd-mmm-yy
Was the subject withdrawn from the study?
Descrizione

* If YES, specify the primary reason.

Tipo di dati

text

Alias
UMLS CUI [1]
C2349954
If Yes, tick the primary reason for withdrawal:
Descrizione

Primary Reason of Withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
If Yes, tick the primary reason for withdrawal: If Other, specify:
Descrizione

Primary Reason of Withdrawal Specification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
UMLS CUI [1,3]
C2348235
Investigator's Signature
Descrizione

Investigator's Signature

Alias
UMLS CUI-1
C2346576
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
Descrizione

Investigature's name

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date of Report
Descrizione

Date of Report

Tipo di dati

date

Unità di misura
  • dd-mmm-yy
Alias
UMLS CUI [1]
C1302584
dd-mmm-yy
Ritorna all'inizio della pagina

Similar models

Study Conclusion GSK Rosiglitazone Alzheimer's disease 100468

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not Applicable (not of childbearing potential or male) (X)
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
Completion, Withdrawal
Item
Date of subject completion or withdrawal
date
C0805732 (UMLS CUI [1])
C2349954 (UMLS CUI [2])
Item
Was the subject withdrawn from the study?
text
C2349954 (UMLS CUI [1])
Withdrawn
Code List
Was the subject withdrawn from the study?
CL Item
Yes* (Y)
CL Item
No (N)
Item
If Yes, tick the primary reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Primary Reason of Withdrawal
Code List
If Yes, tick the primary reason for withdrawal:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropirate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Other (Z)
Primary Reason of Withdrawal Specification
Item
If Yes, tick the primary reason for withdrawal: If Other, specify:
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item Group
Investigator's Signature
C2346576 (UMLS CUI-1)
Investigature's name
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below. Investigator's name (print)
text
C2346576 (UMLS CUI [1])
Date of Report
Item
Date of Report
date
C1302584 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial